Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030. Pfizer Inc (NYSE: PFE) has closed a $43 billion deal to acquire biotechnology...
Tag: Drug
ICPT Stock Tumbles On New Obstacle For Its NASH Drug
Intercept Pharmaceuticals (ICPT) said Friday its experimental liver disease treatment will face a Food and Drug Administration panel in May, leading ICPT stock to tumble. X The FDA’s Gastrointes...
New ‘Fast-Acting’ Migraine Drug Approved By FDA
Topline The Food and Drug Administration on Friday approved a new nasal spray drug giant Pfizer says could offer “fast-acting relief” from migraines, launching a new form of medicine onto the market a...
Mexican Drug Cartel Reportedly Claims Responsibility—And Apologizes—For Abducting And Murdering Americans
Topline Members of a Mexican drug cartel purportedly penned a letter apologizing for kidnapping four Americans and killing two of them last week, and claimed that the individuals responsible for the v...
Sarepta stock surges more than 10% as results top expectations, drug given priority review
Sarepta Therapeutics Inc. SRPT shares rallied in the extended session Tuesday after the biotech drug maker topped Wall Street expectations, and said U.S. regulators granted a priority review status fo...
Scientists Are Testing Virtual Reality For Pain Relief
Earlier this month, scientists published a ground-breaking study in the Journal of Medical Internet Research discussing the efficacy of virtual reality (VR) as a means for pain relief. The study exami...
Maker of Alzheimer drug Leqembi expects FDA’s full approval this summer
Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this s...
The PBM Transparency Act Will Not Lower Drug Prices
While members of Congress agree on the need to try to rein in the prices of prescription drugs, there is less consensus as to how this might be accomplished. Unfortunately, some of the ideas currently...
AXSM Stock Topples As Teva Plans Its Depression Drug Knockoff
Teva Pharmaceutical (TEVA) said Monday it plans a competing knockoff of Axsome Therapeutics‘ (AXSM) new depression treatment, leading AXSM stock to tumble. X Axsome only just gained Food and Dru...
GILD Stock: Gilead Posts Its Best Growth In 7 Years As Cancer Drug Sales Rocket
Gilead Sciences (GILD) crushed fourth-quarter expectations Thursday and issued an unexpectedly bullish outlook that buoyed GILD stock. X The company hasn’t seen growth this strong since 2015 at ...
Amazon’s Bold $5 Prescription Drug Program Is The Future Of Pharmacy
Amazon is taking yet another bold step into the world of healthcare, further solidifying its powerful footprint in the business-to-consumer “B2C” space. Earlier this week, the tech giant announced its...
Police Seize Nearly $2 Million in Crypto from New Zealand Drug Dealers
Crypto crime was a big deal in 2022, and while we’re only a few weeks into 2023, it looks like the trend is continuing after a criminal gang crackdown that resulted in close to $2 million in assets – ...
Amazon Takes On Mark Cuban’s Cost Plus Drug Co. With Subscription Plan As Giants Look To Disrupt $365 Billion Prescription Drug Market
The U.S. healthcare system has long been criticized for its endless inefficiencies and rising costs. Endless horror stories have come out in recent years about people being saddled with six-figure deb...
Amazon Launches $5 A Month Prescription Drug Scheme As It Leaps Further Into Healthcare
Topline Amazon on Tuesday announced a new prescription drug program giving subscribers as many medications as they need for a flat fee, the online retailer’s latest salvo in its bid to lure customers ...
Pharma’s Strategy To Exploit A Depression-Era Antitrust Law Would Raise Drug Costs For Consumers
The prescription drug market is bewildering to many, and its complexity can make rational discussions about the causes of high drug prices exceedingly difficult. It also means that government official...
FTC asks court to hold Martin Shkreli in contempt for launching new drug company
Martin Shkreli, whom you may know as “Pharma Bro,” launched a new company last year called “Druglike, Inc.” Now, the Federal Trade Commission (FTC) has asked a federal judge to...
Lilly’s Alzheimer’s drug setback is ‘not a thesis-breaker’
Eli Lilly & Co (NYSE: LLY) ended slightly down on Friday after the U.S. FDA rejected its request of accelerated approval for Donanemab – its Alzheimer’s drug. Why did the FDA reject its applicatio...
California Sues Eli Lilly And Other Insulin Makers For Driving Up Drug Cost
Topline California is suing a group of pharmacy benefit managers and insulin manufacturers, including pharmaceutical giant Eli Lilly, for using “unlawful, unfair and deceptive” means to drive up the c...
6 Favorite Biotech Bets For 2023
Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation’s leading newsletter advisors. This year’s report is no exception; here’s...
Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire
A pedestrian walks past the Shanghai Stock Exchange in Shanghai in 2020. (Photo by HECTOR … [+] RETAMAL/AFP via Getty Images) AFP via Getty Images Today’s listing at the Shanghai Stock Exchange ...
Merck Rallies to Best Year Since 1995 on Strong Sales, Drug Data
(Bloomberg) — Merck & Co. notched its best yearly gain in more than two decades, making it the top-performing drugmaker in the S&P 500 in 2022 as investors rewarded the company for stron...
Binance Used for Money Laundering by a Drug Cartel: Report
A drug cartel with operations in several countries used Binance to transfer millions in illegal proceeds, according to a U.S. Drug Enforcement Action (DEA) investigation. Forbes noted that the investi...
Binance helps the DEA track down drug cartel
Binance, the world’s largest crypto exchange, is a big target of drug cartels and money laundering. The anonymity provided by cryptocurrencies provides an almost perfect route for cartels to move fun...
Catalyst Pharma Acquires US Rights To Eisai’s Epilepsy Drug
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) agreed to acquire the U.S. rights to Eisai Co Ltd’s (OTC: ESALY) (OTC: ESALF) Fycompa (perampanel) CIII and an exclusive option period to review, eval...
Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug
Shares of Arcus Biosciences Inc. RCUS, -27.76% were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that...
Madrigal Stock Triples After Liver Disease Drug Succeeds in Trial
(Bloomberg) — Madrigal Pharmaceuticals Inc. shares surged 268%, adding about $2.9 billion to its market value, after a late-stage clinical trial of its drug candidate met the main goals in patie...
Viking Therapeutics’ stock rallies after Madrigal shares positive data about its liver drug
Shares of Viking Therapeutics Inc. VKTX, +77.61% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid hormone receptor beta agonist as a treatment for ...
U.S., China Advance Discussions On Pact To Accelerate Cancer Drug Trials
U.S. Food and Drug Administration oncology chief Dr. Richard Pazdur. FDA U.S. and China health experts speaking at an online conference this month suggested that the two countries might be making prog...
Satoshi Nakamoto is a Former Drug Cartel Boss?
Bitcoin’s inception in January 2009 left the whole world in awe as Satoshi Nakamoto opened gates for peer to peer financial transactions. It also raised questions about who this shadowy figure is. To ...